Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 36
1949 87
1950 82
1951 137
1952 130
1953 119
1954 113
1955 154
1956 150
1957 164
1958 158
1959 140
1960 138
1961 130
1962 125
1963 153
1964 185
1965 202
1966 240
1967 272
1968 305
1969 370
1970 354
1971 454
1972 480
1973 410
1974 517
1975 550
1976 722
1977 840
1978 728
1979 678
1980 985
1981 892
1982 884
1983 813
1984 966
1985 959
1986 873
1987 857
1988 833
1989 869
1990 901
1991 994
1992 947
1993 1262
1994 958
1995 747
1996 764
1997 752
1998 785
1999 798
2000 845
2001 773
2002 806
2003 804
2004 756
2005 784
2006 766
2007 737
2008 818
2009 714
2010 1026
2011 1130
2012 959
2013 767
2014 751
2015 768
2016 660
2017 816
2018 742
2019 753
2020 204
Text availability
Article attribute
Article type
Publication date

Search Results

41,678 results
Results by year
Filters applied: . Clear all
Page 1
ESR1 mutations in breast cancer.
Dustin D, et al. Cancer 2019 - Review. PMID 31318440 Free PMC article.
The acquisition of ligand-independent ESR1 mutations during aromatase inhibitor therapy in metastatic estrogen receptor (ER)-positive breast cancer is a common mechanism of hormonal therapy resistance. ...
The acquisition of ligand-independent ESR1 mutations during aromatase inhibitor therapy in metastatic estrogen receptor (ER)-positive breast …
Experiences with cancer survey in China.
Yao N, et al. Cancer 2019. PMID 31067359
BACKGROUND: China accounts for approximately 27% of global cancer deaths. However, to the authors' knowledge, the lasting effects of cancer and cancer treatments on patients have not been investigated in China. ...The majority of Chinese cancer survivors (84%) reported that their work abilities were hindered by their cancer or cancer treatments. ...
BACKGROUND: China accounts for approximately 27% of global cancer deaths. However, to the authors' knowledge, the lasting effects of …
Effects of cancer history on functional age and mortality.
Blair CK, et al. Cancer 2019. PMID 31418826 Free PMC article.
BACKGROUND: Cancer, its treatment, and associated adverse effects may accelerate the functional aging of cancer survivors. In the current study, the authors used geriatric assessment (GA) to compare the functional age of long-term cancer survivors with that of similarly aged women without a cancer history, and to examine whether functional age influences all-cause mortality differently between these 2 groups. ...Mortality risk increased with the increasing number of GA deficits, which was greater in cancer survivors compared with cancer-free women. ...
BACKGROUND: Cancer, its treatment, and associated adverse effects may accelerate the functional aging of cancer survivors. In …
Daratumumab in multiple myeloma
Nooka AK, et al. Cancer 2019 - Review. PMID 30951198
Is cancer prevention influenced by the built environment? A multidisciplinary scoping review.
Wray AJD and Minaker LM. Cancer 2019 - Review. PMID 31287585
Spatial proximity, transportation, land use, and housing are well-understood features of the built environment that shape cancer risk. Built-environment features predominantly influence air quality, substance use, diet, physical activity, and screening adherence, with impacts on breast cancer, lung cancer, colorectal cancer, and overall cancer risk. ...
Spatial proximity, transportation, land use, and housing are well-understood features of the built environment that shape cancer risk …
Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer.
Piawah S and Venook AP. Cancer 2019 - Review. PMID 31433498
Despite recent advances in the management of colorectal cancer, metastatic disease remains challenging, and patients are rarely cured. However, a better understanding of the pathways implicated in the evolution and proliferation of cancer cells has led to the development of targeted therapies, that is, agents with action directed at these pathways/features. ...
Despite recent advances in the management of colorectal cancer, metastatic disease remains challenging, and patients are rarely cured …
Biomarkers in ovarian cancer: To be or not to be.
Arend R, et al. Cancer 2019 - Review. PMID 31967683
Biomarkers are becoming increasingly important in the treatment of epithelial ovarian cancer. Recent work from many laboratories has begun to provide clinically meaningful biomarkers. ...
Biomarkers are becoming increasingly important in the treatment of epithelial ovarian cancer. Recent work from many laboratories has …
GIScience and cancer: State of the art and trends for cancer surveillance and epidemiology.
Sahar L, et al. Cancer 2019 - Review. PMID 31145834 Free PMC article.
Such visualization and analysis provide insights regarding the geographic distribution of cancer and can be important for advancing effective cancer prevention and control programs. ...The authors suggest GIScience is a powerful tool for cancer research, bringing additional context to cancer data analysis and potentially informing decision-making and policy, ultimately aimed at reducing the burden of cancer....
Such visualization and analysis provide insights regarding the geographic distribution of cancer and can be important for advancing e …
Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
Weitzel JN, et al. Cancer 2019. PMID 31206626
BACKGROUND: Breast cancer (BC) is the most common cancer and related cause of mortality among Hispanics, yet susceptibility has been understudied. ...CONCLUSIONS: Of 1054 BRCA-negative, high-risk Hispanic women, 4.5% carried a PV in a cancer susceptibility gene, increasing understanding of hereditary BC in this population. ...
BACKGROUND: Breast cancer (BC) is the most common cancer and related cause of mortality among Hispanics, yet susceptibility ha …
Unlocking the potential of population-based cancer registries.
Tucker TC, et al. Cancer 2019 - Review. PMID 31381143 Free PMC article.
Population-based cancer registries have improved dramatically over the last 2 decades. These central cancer registries provide a critical framework that can elevate the science of cancer research. ...This article describes how central cancer registries can provide a population-based sample frame that will lead to studies with strong external validity, how central cancer registries can link with public and private health insurance claims to obtain complete treatment information, how central cancer registries can use informatics techniques to provide population-based rapid case ascertainment, how central cancer registries can serve as a population-based virtual tissue repository, and how population-based cancer registries are essential for guiding the implementation of evidence-based interventions and measuring changes in the cancer burden after the implementation of these interventions....
Population-based cancer registries have improved dramatically over the last 2 decades. These central cancer registries provide …
41,678 results
Jump to page
Feedback